EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Survival outcomes and prognostic nomogram for primary pulmonary MALT lymphoma and diffuse large B-cell lymphoma: A SEER database study

Jun Li, Yuan Feng, Huaying Zhang, Xin Zhou, Yunyan Tai

Biomolecules and Biomedicine · 2026

DOI: 10.17305/bb.2026.13944 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2026. Verfasst von Jun Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, China. Hauptthemen laut MEDLINE: Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse, Nomograms, Lung Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary pulmonary lymphoma is a rare extranodal malignancy, and robust population-based evidence regarding its treatment and outcomes remains limited. This study aimed to compare treatment patterns and survival outcomes between primary pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma and primary pulmonary diffuse large B-cell lymphoma (DLBCL), as well as to develop an individualized prognostic model for pulmonary DLBCL. Patients diagnosed between 2010 and 2022 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. Propensity score matching (PSM), Kaplan-Meier analysis, and Cox regression were employed to compare survival outcomes and identify prognostic factors. Additionally, a nomogram was constructed and internally validated for DLBCL. Among the 2,343 patients analyzed, 1,427 had MALT lymphoma and 916 had DLBCL. MALT lymphoma was more frequently managed with surgical intervention, while chemotherapy was more commonly utilized for DLBCL. After PSM, 441 matched pairs were analyzed, revealing that MALT lymphoma was significantly associated with better overall survival (OS) and cancer-specific survival (CSS) compared to DLBCL, with median OS of 131 months versus 68 months, respectively (p < 0.001). In patients with DLBCL, age ≥60 years emerged as an independent adverse prognostic factor, whereas surgical intervention and chemotherapy were independently associated with improved OS and CSS. The nomogram demonstrated moderate discrimination and good calibration in predicting 1-, 3-, and 5-year survival. These findings underscore that histological subtype is a critical determinant of prognosis in primary pulmonary lymphoma. The proposed nomogram may facilitate individualized prognostic assessments in pulmonary DLBCL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, B-Cell, Marginal ZoneLymphoma, Large B-Cell, DiffuseNomogramsLung NeoplasmsHumansSEER ProgramFemalePrognosisMiddle AgedMaleAgedAdultKaplan-Meier Estimate

Autor:innen und Institutionen

  • Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
  • Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Ho…
  • Department of Respiratory and Critical Care Medicine, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, China.

Zitieren

APA

Li, J., Feng, Y., Zhang, H., Zhou, X., & Tai, Y. (2026). Survival outcomes and prognostic nomogram for primary pulmonary MALT lymphoma and diffuse large B-cell lymphoma: A SEER database study. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2026.13944

Vancouver

Li J, Feng Y, Zhang H, Zhou X, Tai Y. Survival outcomes and prognostic nomogram for primary pulmonary MALT lymphoma and diffuse large B-cell lymphoma: A SEER database study. Biomolecules and Biomedicine. 2026. doi:10.17305/bb.2026.13944

BibTeX
@article{Li2026,
  author = {Li, Jun and Feng, Yuan and Zhang, Huaying and Zhou, Xin and Tai, Yunyan},
  title = {Survival outcomes and prognostic nomogram for primary pulmonary MALT lymphoma and diffuse large B-cell lymphoma: A SEER database study},
  journal = {Biomolecules and Biomedicine},
  year = {2026},
  doi = {10.17305/bb.2026.13944}
}
Kostenlos starten →